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Abstract
Introduction:  To  evaluate  diagnostic  accuracy  of  high-resolution  ultrasonography  in  differenti-
ation of  benign  and  malignant  thyroid  nodules  in  comparison  to  results  of  guided  ﬁne  needle
aspiration  cytology  based  on  the  Bayes  rule.
Objective:  To  assess  the  validity  of  ultrasonography  results  of  thyroid  nodules  in  comparison  to
guided ﬁne  needle  aspiration  cytology  ﬁndings.
Methods:  This  study  was  done  on  randomly  chosen  80  patients  presented  with  palpable  thy-
roid nodules,  undergone  real-time  sonographic  evaluation  of  thyroid  nodules  to  characterize
features, internal  consistency,  margins,  echotexture,  calciﬁcation,  peripheral  lucent  halo  and
vascularity. Ultrasonography  guided  ﬁne  needle  aspiration  cytology  studies  of  thyroid  nodules
were done.
Results:  Palpable  thyroid  nodules  were  highly  prevalent  in  fourth  and  ﬁfth  decades  of  life  with
female--male  ratio,  4:1.  Solid  internal  consistency  was  demonstrated  by  75%  malignant  nodules.
Hypoechogenicity  and  intra-nodular  micro-calciﬁcations  were  observed  in  92%  malignant  nod-
ules; 83%  malignant  nodules  had  intra-nodular  vascularity  and  absence  of  peripheral  halo.  The
pre-test prevalence  of  malignant  nodules  in  the  targeted  population  was  17.5%.  As  type  I  error,
2.5% false-positive  cases  and  as  type  II  error,  5.0%  false-negative  cases  were  detected.  Values
of sensitivity  and  speciﬁcity  of  the  ultrasonography  test  were  71.43  and  96.97%,  respectively.
Conclusion:  Malignant  thyroid  nodules  demonstrated  ultrasonography  characteristics  of  hypoe-
choic texture,  intra-nodular  micro-calciﬁcations,  solid  consistency,  internal  vascularity  and
absence of  peripheral  halo.  The  ultrasonography  test  has  92.5%  diagnostic  accuracy  to Please cite this article as: Sahu N, Padhy RN. Bayesian analysis of high-resolution ultrasonography and guided ﬁne needle aspiration
cytology in diagnosis of palpable thyroid nodules. Braz J Otorhinolaryngol. 2016. http://dx.doi.org/10.1016/j.bjorl.2016.10.010
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differentiate  malignant  from  benign  lesions  in  comparison  to  the  gold  standard  ﬁne  needle
aspiration  cytology  test.
©  2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
PALAVRAS-CHAVE
Nódulo  maligno  da
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Bócio  coloide;
Ultrassonograﬁa  de
alta  resoluc¸ão;
Regra  de  Bayes;
Sensibilidade  e
especiﬁcidade
Análise  bayesiana  de  ultrassonograﬁa  de  alta  resoluc¸ão  e  guiada  por  citologia  de
aspirac¸ão  por  agulha  ﬁna  no  diagnóstico  de  nódulos  palpáveis  da  tireoide
Resumo
Introduc¸ão:  Avaliar  a  precisão  diagnóstica  da  ultrassonograﬁa  de  alta  resoluc¸ão  na
diferenciac¸ão de  nódulos  tireoidianos  benignos  e  malignos  em  comparac¸ão  com  os  resultados
da citologia  de  aspirac¸ão  por  agulha  ﬁna  baseada  na  regra  de  Bayes.
Objetivo:  Avaliar  a  validade  dos  resultados  da  USG  de  nódulos  da  tireoide  em  comparac¸ão  com
os resultados  obtidos  por  citologia  de  aspirac¸ão  por  agulha  ﬁna.
Método: Esse  estudo  foi  realizado  em  80  pacientes  selecionados  aleatoriamente,  que  apresen-
tavam nódulos  palpáveis  da  tireoide,  submetidos  à  avaliac¸ão  ultrassonográﬁca  em  tempo  real
de nódulos  da  tireoide  para  estabelecer  características,  consistência  interna,  margens,  eco-
textura, calciﬁcac¸ão,  halo  lucente  periférico  e  vascularizac¸ão.  Foram  realizados  estudos  por
citologia  de  aspirac¸ão  por  agulha  ﬁna  guiados  pela  USG  dos  nódulos  de  tireoide.
Resultados:  Nódulos  palpáveis  da  tireoide  foram  altamente  prevalentes  na  quarta  e  quinta
décadas de  vida  com  uma  razão  sexo  feminino-masculino  de  4:  1.  A  consistência  interna  sól-
ida foi  demonstrada  em  75%  de  nódulos  malignos.  Hipoecogenicidade  e  microcalciﬁcac¸ões
intra-nodulares  foram  observadas  em  92%  de  nódulos  malignos;  83%  dos  nódulos  malignos  apre-
sentaram  vascularidade  intra-nodular  e  ausência  de  halo  periférico.  A  prevalência  pré-teste
de nódulos  malignos  na  populac¸ão  alvo  foi  de  17,5%.  Como  erro  tipo  I,  houve  2,5%  de  casos
falso-positivos  e  como  erro  tipo  II,  foram  detectados  5,0%  de  casos  falso-negativos.  Os  valores
de sensibilidade  e  especiﬁcidade  do  exame  por  USG  foram  de  71,43  e  96,97%,  respectivamente.
Conclusão:  Nódulos  malignos  da  tireoide  mostraram  características  de  textura  hipoecoica,
microcalciﬁcac¸ões intra-nodulares,  consistência  sólida,  vascularidade  interna  e  ausência  de
halo periférico  na  USG.  O  exame  por  USG  tem  92,5%  de  precisão  diagnóstica  para  diferenciar
lesões malignas  de  benignas  em  comparac¸ão  com  o  padrão  ouro  da  citologia  de  aspirac¸ão  por
agulha ﬁna.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
ses/
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hyroid  masses  are  usually  abnormal  glandular  swellings,
omprising  of  either  nodular  or  diffuse  enlargements  of
he  gland.  Diffuse  thyroid  masses  are  usually  due  to
enign  causes  such  as,  hyperplastic  colloid  goiter,  chronic
ashimoto’s  thyroiditis  and  Grave’s  disease.1 Nodular  thy-
oid  masses  (TNs)  show  64.6%  prevalence  in  general
opulation  at  autopsy.2 As  the  majority  of  palpable  thy-
oid  nodules  are  benign  in  nature  with  relative  rarity  of
alignancy,  a  reliable  method  for  differentiating  clinically
igniﬁcant  malignant  nodules  from  innocuous  benign  ones
s  desirable.  Early  diagnosis  of  malignant  thyroid  nodules  is
oveted,  because  of  good  post-surgical  prognosis.
The  high-resolution  real-time  gray-scale  ultasonography
USG)  method  has  simpliﬁed  the  evaluation  of  the  anatomy
f  normal  thyroid  and  pathologic  conditions,  with  remark-
ble  clarity;  consequently,  an  accurate  assessment  of  the
ssociated  lesions  can  be  done,  because  of  superﬁcial  loca-
ion  of  the  thyroid  gland.  Detection  of  TNs  by  USG  had
een  reported  to  have  increased  from  19--68%  with  the
h
a
aby/4.0/).
echnological  development  of  ultrasound  equipments.2 USG
eing  a quick  and  non-invasive  procedure  is  the  most
ccepted  imaging  modality  nowadays,  and  as  a  non-ionizing
echnique  it  remains  safe  for  children  and  pregnant  women.
ther  patient-friendly  advantages  are  its  ready  availability,
ow  cost  and  non-requirement  of  any  clinical  manipulation
ith  the  patient  prior  to  carrying  out  the  procedure.  More-
ver,  Thyroid  Imaging  Reporting  and  Data  System  (TI-RADS)  is
 USG  based  study  known  for  a  better  stratiﬁcation  of  sono-
raphically  suspicious  features  of  malignancy.  Furthermore,
he  USG  guided  technique  for  FNAC  procedure  is  concomi-
antly  helpful  in  obtaining  adequate  specimens  even  from
mall  thyroid  nodules.  Today,  high-frequency  transducers
10--13  MHz)  provide  a  greater  degree  of  spatial  resolu-
ion.  On  the  other  hand,  medium-frequency  transducers
5--6.5  MHz)  present  a  good  compromise  between  resolution
s  well  as  penetration  of  deeper  structures  of  neck.
In  this  report,  an  evaluation  of  the  diagnostic  accuracy  of
igh-resolution  USG  ﬁndings  in  the  differentiation  of  benign
nd  malignant  thyroid  nodules,  as  well  as  the  sensitivity
nd  speciﬁcity  of  USG  in  comparison  to  guided  FNAC  results,
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Bayesian  analysis  of  USG  and  FNAC  for  thyroid  nodules  
are  presented.  The  accuracy  of  a  patient-friendly  diagnostic
test,  USG  can  be  measured  by  comparing  with  the  results  of
the  available  gold  standard  test,  FNAC.  From  the  data  the
former  appears  more  undependable  than  the  FNAC  test.  The
available  data  were  analyzed  using  the  Bayes  rule  to  assess
the  USG  test,  as  a  preferential  diagnostic  imaging  modality.
It  is  anticipated  that  this  lamplit  analysis  would  be  helpful  in
quantifying  pervasive  errors  in  these  conventional  diagnos-
tic  methods  for  thyroid  malignancy.  Consequently,  time  and
resources  for  treating  false-positives  (FP)  or  ‘type  I  error’
(USG  test  malignancy,  FNAC  test  benign)  cases  with  dogged
cancer  therapy  would  not  be  wasted,  and  the  spate  of  non-
target  complications  of  the  treatment  could  be  blithely
avoided.  Moreover,  false-negative  (FN)  or  ‘type  II  error’
(USG  test  benign,  FNAC  test  malignancy)  cases  should  not  be
neglected,  since  a  fear  of  future  malignancy  is  generated.
However,  true-positives  (TP)  (USG  test  malignancy,  FNAC
test  malignancy)  and  true-negatives  (TN)  (USG  benign,  FNAC
test  benign)  are  the  sought-after  results  of  a  correct  diagno-
sis.  This  study  further  digitally  compares  USG  ﬁndings  with
a  bond  wagon  of  test  statistics  with  the  gold  standard  (ﬁne
needle  aspiration  cytology)  FNAC  test  conﬁrming  the  use  of
USG  in  the  phase  of  basic  problem  of  interface  of  FNAC  when
rarely  warranted.  Thus,  a  chiaroscuro-like  analysis  of  these
popular  diagnostic  test  methods  for  palpable  thyroid  masses
using  the  Bayes  rule  is  essential  for  assessing  the  diagnostic
accuracy  of  these  tests;  but  that  being  unavailable  in  litera-
ture,  this  work  is  anticipated  to  strengthen  conﬁdence  levels
on  these  tests  in  deciding  whether  an  invasive  corrective
measure  would  be  need  for  a  thyroid  mass.
What  Bayesian  analysis  can  do?
Diagnostic  tests  are  used  for  revealing  the  occurrence  of
randomly  distributed  diseased  individuals  having  both  malig-
nant  and  benign  (absence  of  malignancy)  thyroid  nodules.
The  accuracy  of  a  diagnostic  test  can  be  measured  by  com-
paring  the  test  results  with  the  true  condition  of  patients
individually.  Herein,  the  ambivalence  of  USG  and  FNAC  test
results  for  comparative  accuracy  could  be  resolved  with  the
account  of  data  as  evidence,  by  an  appropriate  statisti-
cal  analysis  involving  probability  --  as  how  much  each  test
is  dependable.  A  clinician  would  be  always  eager  to  know
numerically  about  the  errors  of  each  test,  at  one’s  labo-
ratory  condition.  Obviously,  the  FNAC  test  is  assumed  as
the  gold  standard,  since  it  reveals  the  true  condition  of  a
patient.  Thus,  it  is  an  ideally  based  truth  with  which,  the
second  test,  being  user-friendly  and  patient-friendly  can  be
compared  for  digital  values  as  a  method.  Thus,  the  USG  test
is  the  candidate  to  be  assessed  for  its  sufﬁciency  as  a  diag-
nostic  test.  However,  the  FNAC  test  also  has  a  degree  of
unreliability,  not  having  representable  or  adequate  thyroid
tissue  from  the  appropriate  nodule  consequent  to  improper
placement  of  guided  needle  tip  due  to  technical  error.  Thus
prudently,  the  Bayesian  analysis  based  on  obtained  data  as
evidence  could  measure  the  degree  of  belief/assumption,
for  what  percent  the  FNAC  test  could  be  taken  as  gold
standard,  and  concomitantly,  how  much  numerically  the  USG
test  would  be  dependable.  To  evaluate  the  inherent  prob-
ability  of  each,  the  prior  probability  (a  priori  probability
or  prevalence  or  the  prevalence  of  thyroid  malignancy  in
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he  targeted  population)  was  determined  before  using  data,
revalence  =  [(TP  +  FN)/n], with  n  =  number  of  total  number
f  thyroid  masses.  And  both  tests  are  independent  by  them-
elves,  but  are  critical  in  determining  the  status  of  each
est.  Furthermore,  there  are  several  associated  test  statis-
ics:  the  sensitivity  (true  positive  rate)  --  this  is  the  portion
f  the  people  with  the  disease  (malignancy),  who  will  have
ositive  USG  test  results,  computed  by  [TP/(TP  +  FN)],  and
he  speciﬁcity  (true  negative  rate)  --  this  is  the  portion  of
he  people  without  the  disease,  who  will  have  benign  nodule
n  USG  test  results,  computed  by  [TN/(FP  +  TN)];  these  test
tatistics  are  bases  of  the  Bayesian  analysis.3
Furthermore,  the  false  positive  rate  --  it  is  the  probabil-
ty  of  errors  of  the  FNAC  test,  computed  by  [FP/(FP  +  TN)],
nd  the  false  negative  rate  --  it  is  the  probability  of  errors
f  the  USG  test,  computed  by  FN/(TP  +  FN)  are  important.
nd  the  positive  predictivity  --  it  is  the  post-test  probabil-
ty  of  the  disease  that  gave  a  positive  test  result  or  this  is
he  portion  of  the  people  who  actually  have  thyroid  malig-
ancy,  computed  by  [TP/(TP  +  FP)],  predicted  positivity  by
he  USG  test;  and  the  negative  predictivity  --  post-test  prob-
bility  of  the  disease  that  gave  a negative  test  result  or  this
s  the  portion  of  the  people  negative  for  malignancy,  com-
uted  by  [TN/(FN  +  TN)],  predicted  negativity  (absence  of
alignancy)  by  the  USG  test.  Also  the  diagnostic  accuracy
inherent  validity  or  predictive  validity)  --  it  is  the  ability  of
he  USG  test  to  be  correctly  positive  or  negative,  computed
y  [(TP  +  TN)/n]. Furthermore,  the  positive  likelihood  ratio
s  the  ratio  between  TP  rate  and  FP  rate,  computed  by  [sensi-
ivity/(1  −  speciﬁcity)],  when  the  USG  test  result  is  positive;
nd  the  negative  likelihood  ratio  is  the  ratio  between  FN
ate  and  TN  rate,  computed  by  [(1  −  sensitivity)/speciﬁcity],
hen  the  USG  test  result  is  benign.  The  larger  the  posi-
ive  likelihood  ratio  value,  the  greater  is  the  likelihood  of
alignant  nodules,  and  similarly,  the  smaller  the  negative
ikelihood  ratio  value,  the  lesser  is  the  likelihood  of  malig-
ancy,  in  a  population.  And  a  posteriori  probability  is  the
alue  from  post-test  arithmetic  computation  of  the  data  for
iagnostic  efﬁciency,  and  it  speciﬁcally  analyses  how  much
numerically)  good/dependable  the  test  is,  independently
n  arriving  at  the  truth--the  coveted  conclusions  from  these
ests  on  individual  patients.
ethods
he  present  work  on  high-resolution  real-time  sonographic
valuation  of  palpable  thyroid  nodules  was  carried  out  in
epartment  of  Radiodiagnosis.  It  is  a  prospective  study
onducted  on  randomly  chosen  80  patients  of  both  sexes  pre-
ented  with  palpable  thyroid  nodules,  over  a  2  year  period
Feb  2013--Dec  2014)  in  the  eastern  costal  region  of  India.
he  correlation  of  USG  ﬁndings  with  guided  FNAC  results
ere  carried  out.  The  study  excluded  cases  having  ques-
ionably  palpable  thyroid  nodules,  diffuse  thyroid  masses
nd  chronic  renal  failure,  in  which  parathyroid  nodules  may
oexist.
Real-time  sonographic  evaluation  was  performed  on
EDISON  ACCUVIX  A30  Scanner,  installed  in  the  depart-
ent  using  a  linear  transducer  having  wide  range
requency  of  5--13  MHz  providing  both  high  resolution
nd  deeper  penetration  as  well.  Evaluation  of  thyroid
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Table  1  Age  and  sex  distribution  of  thyroid  nodules  of  80  cases.
Sex  21--30  y  31--40  y  41--50  y  51--60  y  Total
Male  02  07  06  01  16  (20)
Female 08  31  22  03  64  (80)
Total 10  (12.5)  38  (47.5)  28  (35)  04  (5)  80  (100)
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A  posteriori  probability
The  a  posteriori  probability  or  ‘p(E1|E)’,  the  probabil-
ity  value  of  a  thyroid  mass  to  be  truly  positive,  could
Table  2  Number  of  patients  with  different  ultrasonography
(USG)  features  of  benign  and  malignant  nodules,  distributed
among  80  cases.
USG  features  Benign
nodules
Malignant
nodules
Internal  consistency
Solid  48  09
Mixed  cystic  16  03
Cystic  04  --
Margins
Regular  50  02
Irregular/microlobulated  04  10
Echotexture
Hyperechoic  32  --
Isoechoic  18  --
Hypoechoic  02  11
Heteroechoic  12  01
Anechoic  04  --
Calciﬁcation
Coarse  (macro)  20  --
Fine  (micro)  01  11
Peripheral  lucent  halo
Thin  complete  56  01
Thick  incomplete/absence  02  10
Vascularity
Peripheral  36  02y, years; numbers in parenthesis are percent values.
odules  were  done  to  characterize  sonographic  features
uch  as,  internal  consistency  (solid/mixed  cystic/cystic),
argins  (regular/irregular),  echotexture  (hyper/iso/hypo/
etero/anechoic),  calciﬁcation  (coarse/ﬁne),  peripheral
ucent  halo  (thick/thin,  complete/incomplete)  and  intrale-
ional  vascularity  status  on  Color  Doppler  Flow  Imaging
CDFI).  The  presence  of  additional  features,  intra-nodular
emorrhage,  comet-tail  artifacts  and  cervical  lymphadeno-
athy  were  also  monitored.  USG  ﬁndings  were  correlated
ith  guided  FNAC  reports  to  determine  its  sensitivity  and
peciﬁcity  values.
esults
sually  TNs  measuring  above  1.5  cm  are  palpable  clinically.
he  age  of  the  total  80  patients  presented  with  palpable
Ns  ranged  from  21--60  years,  with  a  female--male  ratio  of
:1.  In  the  age  group  of  31--40  years,  38  (47.5%)  cases  and  in
he  age  group  of  41--50  years,  28  (35%)  cases  of  the  total  80
ases  had  palpable  TNs  (Table  1).  Moreover,  at  21--50  year
roup,  95%  benign  cases  were  noted.  Furthermore,  92%  cases
f  malignant  nodules  were  presented  in  the  ﬁfth  and  sixth
ecades  of  life  with  a  female  male  ratio  of  3:1.
Of  the  total  80  cases,  a  major  fraction  of  68  (85%)  cases
ere  benign,  of  which  only  hyperplastic  colloid  nodules  com-
rised  of  64  cases.  Malignant  nodules  were  detected  in  12
15%)  cases.  Only  71%  of  the  total  thyroid  nodules  were
olid,  while  24%  nodules  exhibited  mixed  cystic  changes.
ine  out  of  12  cases  among  malignant  nodules  demon-
trated  solid  consistency.  Hypoechogenicity  was  observed  in
1  out  of  12  malignant  nodules;  and  half  of  the  total  benign
odules,  demonstrated  hyperechogenicity.  Incidences  of
ntra-nodular  calciﬁcation  were  recorded  in  92%  malignant
odules  and  31%  benign  nodules.  Furthermore,  thick  incom-
lete  or  absence  of  perinodular  sonolucent  halo  was  noted
n  10  out  of  12  malignant  cases.  Intra-nodular  vascularity
as  too  observed  in  10  out  of  12  malignant  nodules,  while
he  rest  2  cases  had  peripheral  vascularity.  Cervical  lympha-
enopathy  was  demonstrated  by  10  malignant  cases  out  of
hich,  only  2  cases  had  cystic  consistency  (Table  2).
Of  the  total  of  80  (1.0)  evaluated  cases,  it  was  found  that
2  (0.15)  cases  were  with  malignant  nodules  and  the  rest  68
0.85)  cases  had  benign  nodules  in  USG  test  results;  whereas
4  (0.175)  cases  were  malignant  from  FNAC  test  results,
nd  the  rest  66  (0.825)  cases  had  FNAC-benign  nodules;  test
esults  of  all  cases  got  Balkanized  to  four  categories  as  TP,
N,  FP  and  FN  cases  in  Table  3.  In  other  words,  there  was mismatching  of  USG  test  and  FNAC  test  results.  The  total
f  14  malignant  (TP  +  FN)  cases  signify  that  the  prevalence
f  malignancy  was  17.5%  (probability  value,  0.175),  in  the
argeted  population  of  80  cases.The  sensitivity  value  is  the  ability  of  the  USG  test  to
etect  the  malignancy  status,  when  it  is  truly  present,  i.e.,
t  is  the  probability  of  a  ‘positive  test  result’.  On  the  other
and,  the  speciﬁcity  value  is  the  ability  of  the  USG  test  to
ive  the  negative  result  with  malignancy-free  individuals,
.e.,  it  is  the  probability  of  a  ‘negative  test  result’.  Addi-
ionally,  the  diagnostic  accuracy  value  estimates  accuracy  of
oth  USG  and  FNAC  tests  together.  And  applying  the  Bayesian
oncept  with  these  recorded  data  (Table  3),  a  bandwagon  of
ther  test  statistics  could  be  computed  for  additional  proba-
ility  values,  along  with  their  corresponding  95%  conﬁdence
nterval  (CI)  values  (Table  4).Internal  08  10
Avascular  24  --
Lymphadenopathy  06  08
--, not found.
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Table  3  The  generic  2  ×  2  table  with  number  of  cases  assigned  to  malignant  and  benign  nodules,  based  on  USG  test  and  ﬁne
needle aspiration  cytology  (FNAC)  test  during  diagnosis  of  thyroid  nodules.
USG  test  results  FNAC  test  results  Total
Malignant  nodules  Benign  nodules
Malignant  nodules  TP  =  10  (0.125)  FP  =  02  (0.025)  (TP  +  FP)  =  12  (0.15)
Benign nodules  FN  =  04  (0.05)  TN  =  64  (0.8)  (FN  +  TN)  =  68  (0.85)
Total (TP  +  FN)  =  14(0.175)  (FP  +  TN)  =  66  (0.825)  n  =  80  (1.0)
TP, 10 cases were true-positives (USG-malignancy, FNAC-malignancy); FP, 02 cases were false-positives (USG-malignancy, FNAC-benign);
FN, 04 cases were false-negatives (USG-benign, FNAC-malignancy); and TN, 64 samples were true-negatives (USG-benign, FNAC-benign);
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hn, population size or total number of cases. Corresponding fracti
in the population was 0.175. FP cases are the type I errors, while
be  calculated  by  the  Bayesian  formula,  p(E1|E)  =  p(E1)  ×
p(E|E1)/[p(E1)  ×  p(E|E1)  +  p(E′1)  ×  p(E|E′1)],  where,  E  is  the
event  that  the  USG  test  result  is  malignant;  E1 is  the  event
that  the  same  case  has  the  FNAC  test  result  positive;  E′1 is
the  partition  of  the  space  for  all  cases  from  healthy  (with-
out  any  malignancy  in  the  palpable  thyroid  mass)  and  it  is  a
recorded  value.
Here  several  probability  values  are,  p(E)  =  probability
of  USG  test  malignancies  =  0.15  from  Table  3; p(E1)  =
probability  of  FNAC  test  malignancy  (TP  +  FN)  =  0.175
from  Table  3.  Thus,  p(E|E1)  =  0.15/0.175  =  0.857;  p(E′1)  =
probability  of  TP  =  0.125;  p(E|E′1)  =  probability  of
(TP  +  TN)  =  0.125  +  0.8  =  0.925.
As  we  seek  the  a  posteriori  probability  value,  substituting
above  values  in  its  formula,  p(E1|E)  =  p(E1)  ×  p(E|E1)/
[p(E1)  ×  p(E|E1)  + p(E′1)  ×  p(E|E′1)],  we  get,  p(E1|E)  =
(0.175  ×  0.857)/[0.175  ×  0.857)  +  (0.125  ×  0.925)]  =  0.14997/
[0.14997  +  0.11562]  =  0.564667.
Thus,  p(E1|E)  or  a  posteriori  probability  value  =  0.564667
or  0.5647.
DiscussionFor  a  better  stratiﬁcation  of  malignant  risk  of  TNs,  this  study
deals  with  several  suspicious  USG  features  such  as,  hypoe-
choic  texture,  solid  consistency,  ﬁne  microcalciﬁcations,
irregular  microlobulated  margin,  intranodular  vascularity
n
h
i
n
Table  4  Computed  probability  values  of  different  Bayesian  test  s
Test  statistic  Formula  
Prevalence  or  a  priori  probability  (TP  +  FN)/N  
Sensitivity (true  positive  rate)  TP/(TP  +  FN)  
Speciﬁcity (true  negative  rate)  TN/(FP  +  TN)  
Diagnostic accuracy  (TP  +  TN)/Na
Positive predictivity  TP/(TP  +  FP)  
Negative predictivity  TN/(FN  +  TN)  
False positive  rate  FP/(FP  +  TN)  =  (1  −  s
False negative  rate  FN/(TP  +  FN)  =  (1  −  s
Positive likelihood  ratio  Sensitivity/(1  −  spe
Negative likelihood  ratio  (1  −  sensitivity)/spe
A posteriori  probability  p(E1|E)  
CI, conﬁdence interval. For the detailed formula of a posteriori probab
a Alternately, (sensitivity) (prevalence) + (speciﬁcity) (1 − prevalencelues are given in parentheses. Prevalence of thyroid malignancy
ases are the type II errors.
nd  absence  of  surrounding  halo,  as  reported  earlier.4,5
oexistence  of  at  least  two  suspicious  USG  features  is  known
o  increase  the  risk  of  malignancy  and  further  increase  of
he  number  of  suspicious  USG  features  increases  the  cancer
isk  many  fold.6 Moreover,  associated  cervical  lymphadeno-
athy  as  seen  in  this  study  also  contributed  to  the  increase  of
alignant  risk,  corroborating  the  report  of  Sanchez.2 Even-
ually,  unnecessary  FNAC  of  a  majority  of  TNs  are  precluded.
Hyperplastic  colloid  nodules  comprised  of  a  major  frac-
ion,  80%  (64  out  of  80)  of  the  total  cases,  as  in  a  report.7
he  majority  (92%)  of  malignant  TNs  had  female  predom-
nance  (female:  male  ratio:  3:1)  with  a  peak  of  incidence
etween  40  and  60  years  of  age,  corroborating  the  report
f  Clark  et  al.8 Of  the  total,  only  16  benign  colloid  nod-
le  cases  had  features  of  multi-centricity  presenting  with
dditional  nodules  corroborating  well  with  a  study  reported
y  Marquese  et  al.9 Solid  and  predominantly  solid  (contain-
ng  less  than  50%  cystic  areas)  lesions  had  high  predilection
or  being  malignant.10--12 Echotexture  of  normal  thyroid  tis-
ue  remains  slightly  hyperechoic  than  the  cervical  strap
uscles  present  anterior  to  the  thyroid  gland.  Hypoechoic
hyroid  nodules  appear  relatively  hypoechoic  in  compari-
on  to  these  anterior  strap  muscles,  as  reported.13 Marked
ypoechoic  pattern  was  observed  in  11  of  12  malignant
odules,  thus  favoring  the  diagnosis  of  malignancy.  Around
alf  of  the  benign  lesions  demonstrated  hyperechogenic-
ty,  a  clear  indicator  of  benignity,  while  the  rest  of  benign
odules  appeared  isoechoic.12,14 None  of  the  malignant
tatistics  of  diagnosis  of  thyroid  tumors.
Value  95%  CI
0.1750  0.7560--1.1390
0.7143  0.8388--1.0612
0.9697  0.9139--1.9860
0.9250  0.8930--1.0010
0.8333  0.8651--1.0349
0.9412  0.8996--1.0040
peciﬁcity)  0.0303  0.7451--1.1549
ensitivity)  0.2857  0.7741--1.1259
ciﬁcity)  2.3573  0.7090--1.1910
ciﬁcity  0.2946  0.7752--1.1248
0.5647  0.8127--1.0873
ility see text.
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odules  was  having  any  purely  hyperechoic  or  anechoic
chotexture.  Calciﬁcation  of  thyroid  nodules  was  presented
s  both  ﬁne  (micro)  and  coarse  (macro)  patterns,  in  40%
he  total  80  cases.  The  highest  incidence  of  ﬁne  micro-
alciﬁcation  was  found  in  11  of  12  malignant  nodule  cases,
hile  20  out  of  21  calciﬁed  benign  nodules  demonstrated
oarse  macro-calciﬁcations.  The  present  study  corroborates
he  presence  of  pertinent  sonological  features,  anechoic
r  completely  cystic  structure,  hyperechogenicity,  and
acro-calciﬁcations  were  speciﬁc  in  classifying  a  nodule  as
enign.15 Incidence  of  malignancy  was  signiﬁcantly  higher
n  the  calciﬁed  nodules.16,17 Hence,  it  could  be  stated  that
 low  incidence  of  malignancy  can  be  predicted  in  patients
ith  non-calciﬁed  thyroid  nodules.
Thin  complete  perinodular  sonolucent  halo,  caused  by
ither  the  capsule  or  the  surrounding  vessels  were  demon-
trated  in  56  (including  all  the  hyperechoic  and  isoechoic
odules)  of  68  benign  nodules.  Thick  incomplete  or  absence
f  peripheral  halo  was  noted  in  the  majority  (82%)  of  malig-
ant  cases,  thought  to  be  due  to  the  compression  of  normal
hyroid  tissue  by  the  rapid  growth  of  tumors14;  perinodu-
ar  thyroid  parenchymal  invasion  too  causes  the  absence  of
eripheral  halo.  Cystic  degeneration  was  present  in  16  cases
f  benign  thyroid  nodules,  usually  due  to  the  colloid  degen-
ration  of  hyperplastic  nodules.  Three  cases  of  malignant
odules  demonstrated  intranodular  cystic  changes.  In  this
tudy  10  out  of  12  malignant  nodule  cases  demonstrated  cen-
ral  color  ﬂow  pattern  on  CDFI,  suggestive  of  intra-nodular
ascularity  in  predominantly  solid  malignant  nodules,  as
eported.18 Enlargement  of  multiple  lymph  nodes  in  the  lat-
ral  cervical  nodal  chain  was  present  in  10  of  12  malignant
odule  cases.  Most  of  the  lymph  nodes  were  rounded  and
ypoechoic,  as  compared  to  the  thyroid  tissue.  Cystic  cervi-
al  lymphadenopathy  was  noted  in  two  papillary  carcinoma
ases.
All  values,  except  likelihood  ratios  of  Table  4,  are  cited
erein  as  percentages.  The  prevalence  (a  priori  probability
r  the  pre-test  probability  or  the  presence  of  malignancy  in
he  population)  value  was  17.5%,  as  there  were  a  total  of
4  FNAC  malignancy  (TP  +  FN)  cases.  And  from  incidences
f  both  false  cases  (FN  and  FP),  it  was  discernible  that
ach  test  alone  was  insufﬁcient  for  the  diagnosis  of  malig-
ancy.  Further,  both  positive  predictivity  value  (0.8333%  or
3.33%,  the  fallibility  of  16.67%)  and  negative  predictivity
alue  (0.9412%  or  94.12%,  a  moderate  fallibility  of  5.88%)
re  computed,  which  are  dependent  on  the  prevalence  of
he  disease;  both  these  values  indicated  distinguishing  efﬁ-
iency  of  the  USG  test,  the  former  for  the  presence  and  the
ater  for  the  absence  of  malignancy,  correctly.19 The  former
s  the  conditional  probability  value  that  a  patient  had  the
isease,  given  that  the  USG  test  result  was  indicative  of
alignancy.  Similarly,  the  latter  is  the  conditional  proba-
ility  that  a  patient  did  not  have  the  malady,  given  that  the
SG  test  result  indicated  negativity  for  malignancy.
Moreover,  two  important  test  statistics,  sensitivity  and
peciﬁcity  are  conditional  of  either  having  or  not  having
he  malignancy  in  a  nodule  of  a  patient  and  both  are  not
ffected  by  the  prevalence  value.  The  sensitivity  of  the
SG  test  was  0.7143%  or  71.43%;  consequently,  this  ﬁg-
re  strongly  underrates  the  USG  test  to  be  an  insufﬁcient
ethod  for  the  diagnosis,  in  the  presence  of  a  stable  mal-
dy.  A  high,  exquisite  value  of  the  speciﬁcity  (0.9697%  or
a
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6.97%),  however,  suggests  an  absolute  dependency  on  the
SG  test  at  the  absence  of  malignancy,  on  the  contrary.
erein,  to  resolve  this  ambivalence,  i.e.,  to  provide  an  unbi-
sed  estimation  of  accuracy  from  the  USG  test,  one  would
se  the  known  correction  method,  based  on  sensitivity  and
peciﬁcity  together,  in  a  cumulative  concept.  In  a  balance,
his  value  would  be  84.2%  [71.43  +  96.97)/2  =  84.2%];  in  other
ords,  for  84.2%  cases  the  USG  test  would  be  dependable,
or  the  diagnosis  of  thyroid  malignancy  in  comparison  to
he  FNAC  test.  In  addition,  the  diagnostic  accuracy  value
xamines,  by  how  common  the  USG  test  is  effective  and  the
oderately  high  accuracy  value  of  0.9250%  or  92.5%  signi-
es  a  proportionately  high  reliance  on  the  USG  test,  for  the
ubsequent  management  if  malignancy  is  diagnosed,  when
he  FNAC  test  result  was  still  unknown;  this  value  indicates
ccuracy  of  the  USG  test,  regardless  of  positive  or  negative
esult  of  FNAC.  Furthermore,  the  positive  likelihood  ratio  of
.3573  is  a  measure  of  the  diagnostic  accuracy  from  another
ngle;  its  magnitude  indicated  the  certainty  of  a  positive
iagnosis  of  the  USG  test.  Similarly,  the  negative  likelihood
atio  (0.2946)  indicated  its  certainty  of  a  negative  diagno-
is.  Indeed,  there  would  not  be  any  dilemma  on  the  USG
est  account,  since  a  clinician  inveterately  advises  for  a  USG
est  in  case  of  a  palpable  thyroid  mass,  as  a  part  of  the
outine  preemptive  practice.  Thus,  the  64  TN  cases  (80%)
re  justiﬁed.  Admittedly,  it  is  the  most  frequently  followed
reliminary  method  of  diagnosis,  rather  safe  and  low-cost
ethod  being  quick  and  non-invasive  with  the  diagnostic
rotocol.  Moreover,  the  amount  of  02  FP  cases  (2.5%)  of
he  total  USG  test  results  could  be  due  to  some  insinuating
uman  error  of  aspirating  cells  from  the  perinodular  tissue
issing  the  target  nodule  resulting  in  inadequate  samp-
ing  during  the  guided  FNAC  test  procedure.  The  assertive
tatement  now  would  be  that  the  USG  and  FNAC  test  had
 56.47%  chance  of  correctly  distinguishing  a  thyroid  mass
or  presence/absence  of  malignancy,  as  inferred  from  the  a
osteriori  probability  value  of  0.5647.  If  the  pre-test  prob-
bility  (prevalence)  of  a  disease  would  be  lower  as  here,
7.5%,  then  the  binary  predictivity  values  of  a  positive  test
ould  be  also  lower.  In  this  study,  both  the  predictive  values
ositive  predictivity  83.33%  and  negative  predictivity  94.12%
ndicate  two  independent  assumptions:  the  USG  test  would
e  correct  for  83.33%  cases  and  the  FNAC  test  would  be
ccurate  for  94.12%  cases,  when  malignancy  is  prevalent  in  a
atient.  In  the  present  case  both  the  predictivity  values  are
igher  (positive  83.33%  and  negative  94.12%).  So,  from  the
egative  predictive  value  of  94%  (high  level),  the  sufﬁciency
f  FNAC  test  is  indicated,  with  a  conﬁdence.  Moreover,  the
andwagon  of  values  of  associated  test  statistics  generated
n  the  Bayesian  analysis  clump  around  the  data-set,  facilitat-
ng  a  multiple  evaluation  of  the  ambivalence  with  generated
igital  values  of  both  tests.  The  value  of  a  posteriori  proba-
ility,  0.5647  from  the  post-test  arithmetic  computation  of
he  data  estimates  a holistic  diagnostic  efﬁciency  of  both
ests,  and  it  speciﬁcally  analyses  how  much  (numerically)
ood  each  test  is  at  independently  arriving  at  the  truth  --
he  coveted  conclusions  from  these  tests.  Thus,  this  analysis
ould  provide  a methodological  framework  of  quantitative
ssessment  of  two  test  results  of  diagnosis  of  malignancy  in
 thyroid  mass,  as  concluded  for  another  issue.20
The  TI-RADS  is  basically  a  USG  classiﬁcation.  Normal
hyroids  with  no  evidence  of  focal  lesion  are  classiﬁed  as
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TI-RADS  category  1,  and  benign  thyroid  nodules  are  the  cat-
egory  2;  the  category  3  includes  probably  benign  thyroid
nodules  with  <5%  risk  of  malignancy.2 Undetermined  nod-
ules  with  5--10%  risk  of  malignancy  are  classiﬁed  under  the
category  TI-RADS  4a;  TNs  classiﬁed  as  category  4b  are  sus-
picious  nodules  with  10--50%  risk  of  malignancy;  and  highly
suspicious  nodules  with  50--85%  risk  of  malignancy  are  classi-
ﬁed  as  category  4c.  The  category  TI-RADS5  includes  probably
malignant  nodules.4,5 The  category  TI-RADS  6  includes  biopsy
proved  malignant  TNs.  Thyroid  nodules  of  categories  TI-
RADS  3,  4a,  4b,  4c  and  5  should  always  undergo  FNAC  for
histological  conﬁrmation,  except  if  contraindicated  or  in
the  event  of  high  risk.  In  fact,  color  Doppler  or  elastogra-
phy  and  scintigraphy  or  PET/CT  could  be  used  in  suspected
cases  (probably  benign)  of  the  category  3,  while  in  category
2  benign  cases,  FNAC  and  surgery  would  not  be  performed.
Moreover,  the  requirement  of  the  aggressive  approach  of
FNAC  may  become  redundant;  nevertheless  this  is  the  gold
standard  test  for  diagnosis  of  malignancy.  This  work  corrob-
orates  the  recent  developments  of  TI-RADS,  with  the  most
popular  statistical  view  point  with  digital  values  of  depend-
ency  on  the  USG  assessment.
Limitations  of  the  statistical  analysis
Several  limitations  of  this  analysis  are  signposted:  (1)  when
the  sensitivity  value  is  higher,  it  would  be  easier  to  detect
positivity  (malignancy)  in  a  population  by  the  USG  test;  (2)
high  values  of  sensitivity  and  speciﬁcity  are  not  affected
by  prevalence  of  the  disease  (malignancy)  in  a  population;
(3)  albeit  the  speciﬁcity  value  was  as  high  as  99%  herein,  it
does  not  prompt  that  the  accuracy  of  the  USG  test  is  equally
high.  Thus,  neither  the  patient  nor  the  clinician  can  get
an  answer  for  the  question,  what  is  the  probability  of  the
disease  inferred  from  the  positivity  of  the  USG  test;  (4)  as
in  the  present  study,  there  was  as  a  low  level  of  the  error
2.5%  (2  FP  cases)  insinuated  into  the  FNAC  test  result,  there
should  not  be  any  objection  for  using  it  as  the  gold  standard
(veriﬁcation  bias)  test.
Conclusion
The  majority  of  thyroid  nodules  were  benign.  Malignant
thyroid  nodules  demonstrated  USG  characteristics  of  hypoe-
choic  texture,  ﬁne  micro-calciﬁcations,  solid  consistency,
internal  vascularity  and  absence  of  surrounding  halo.  High
sensitivity  and  speciﬁcity  of  the  USG  modality  in  relation
to  the  gold  standard  guided  FNAC  results  showed  increas-
ing  importance  of  its  diagnostic  utility  to  differentiate
malignant  from  benign  lesions.  Seen  through  Bayesian
spectacles,  it  could  be  concluded  that  the  USG  test  of  a
thyroid  mass  was  efﬁcient  by  71.43--96.97%,  in  arriving
at  a  positive  result  for  the  diagnosis  of  malignant  thyroid
nodules,  when  its  FNAC  test  was  positive.  Herein,  the
prevalence  of  thyroid  malignancy  was  17.5%,  while  the
post-test  probability  value  with  both  USG  and  FNAC  tests
in  differentiating  malignant  from  the  benign  lesions  was
56.47%,  as  inferred  from  the  a  posteriori  probability  value.
Obviously,  an  early,  accurate  and  hone  diagnosis  of  thyroid
malignancy  still  remains  the  mainstay  of  inclusion  criteria
for  FNAB  procedures  and  an  important  objective  for  a
1 PRESS
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imely  implementation  of  corrective  surgical  intervention,
or  the  reduction  of  associated  comorbidities  as  well  as,
he  metastatic  spread  of  this  grisly  disease  to  innards.
onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
cknowledgements
his  work  has  institutional  ethical  committee  approval  pro-
ocol  number  CRL/IEC/2013-104,  dated,  4  January  2013.  We
re  grateful  to  Prof.  Dr.  Gangadhar  Sahoo,  Dean,  IMS  &  Sum
ospital  for  encouragements.
eferences
1. Salvatori M, Melis L, Castaldi P, Maussier ML, Ruﬁni V, Perotti
G, et al. Clinical signiﬁcance of focal and diffuse thyroid dis-
eases identiﬁed by (18)f-ﬂuorodeoxyglucose positron emission
tomography. Biomed Pharmacother. 2007;61:488--93.
2. Sanchez JF. TI-RADS classiﬁcation of thyroid nodules based on a
score modiﬁed according to ultrasound criteria for malignancy.
Rev Argent Radiol. 2014;78:138--48.
3. Zhou XH, Obuchowski NA, McClish DK. Statistical methods in
diagnostic medicine. 2nd ed. New York: John Wiley & Sons;
2011, http://dx.doi.org/10.1002/9780470906514.
4. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al.
Thyroid imaging reporting and data system for US features of
nodules: a step in establishing better stratiﬁcation of cancer
risk. Radiology. 2011;260:892--9.
5. Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY. Malignancy
risk stratiﬁcation of thyroid nodules: comparison between the
thyroid imaging reporting and data system and the 2014 Amer-
ican Thyroid Association Management Guidelines. Radiology.
2016;278:917--24.
6. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L,
et al. American Association of Clinical Endocrinologists, Associ-
azione Medici Endocrinologi, and European Thyroid Association
Medical guidelines for clinical practice for the diagnosis and
management of thyroid nodules: executive summary of recom-
mendations. J Endocrinol Invest. 2010;33 Suppl.:51--6.
7. Tan GH, Gharib H. Thyroid incidentalomas: management
approaches to nonpalpable nodules discovered incidentally on
thyroid imaging. Ann Intern Med. 1997;126:226--31.
8. Clark KJ, Cronan JJ, Scola FH. Color Doppler sonography:
anatomic and physiologic assessment of the thyroid. J Clin
Ultrasound. 1995;23:215--23.
9. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen
PR, Cibas ES, et al. Usefulness of ultrasonography in the
management of nodular thyroid disease. Ann Intern Med.
2000;133:696--700.
0. Baier ND, Hahn PF, Gervais DA, Samir A, Halpern EF, Mueller
PR, et al. Fine-needle aspiration biopsy of thyroid nodules:
experience in a cohort of 944 patients. AJR Am J Roentgenol.
2009;193:1175--9.
1. Popli MB, Rastogi A, Bhalla PJS, Solanki Y. Utility of gray scale
ultrasound to differentiate benign from malignant thyroid nod-
ules. Indian J Radiol Imaging. 2012;22:63--8.
2. Rahimi M, Farshchian N, Rezaee E, Shahebrahimi K, Madani H. To
differentiate benign from malignant thyroid nodule comparison
of sonography with FNAC ﬁndings. Pak J Med Sci. 2013;29:77--80.
3. Choi YJ, Yun JS, Kim DH. Clinical and ultrasound fea-
tures of cytology diagnosed follicular neoplasm. Endocr J.
2009;56:383--9.
 IN+Model
8
1
1
1
1
1
1ARTICLE
 
4. Kovacevic DO, Skurla MS. Sonographic diagnosis of thyroid nod-
ules: correlation with the results of sonographically guided
ﬁne-needle aspiration biopsy. J Clin Ultrasound. 2007;35:
63--7.
5. Srinivas MN, Amogh VN, Gautam MS, Prathyusha IS, Vikram NR,
Retnam MK, et al. A prospective study to evaluate the reliability
of thyroid imaging reporting and data system in differentiation
between benign and malignant thyroid lesions. Clin Imaging Sci.
2016;26:5.
6. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of
thyroid nodules as assessed by sonographic criteria: the need
for biopsy. J Ultrasound Med. 2004;23:1455--64.
2 PRESS
Sahu  N,  Padhy  RN
7. Ugurlu S, Caglar E, Yesim TE, Tanrikulu E, Can G, Kadioglu P.
Evaluation of thyroid nodules in Turkish population. Intern Med.
2008;47:205--9.
8. Ahmed Z, Khan MA, ul Haq A, Attaullah S, ur Rehman J. Effect
of race, gender and age on thyroid and thyroid stimulating hor-
mone levels in North West Frontier Province, Pakistan. J Ayub
Med Coll Abbottabad. 2009;21:21--4.
9. Altman DG, Bland JM. Statistics notes: diagnostic tests 2: pre-
dictive values. BMJ. 1994;309:102.
0. Rath S, Panda M, Sahu MC, Padhy RN. Bayesian analysis of
two diagnostic methods for paediatric ringworm infections in
a teaching hospital. J Mycol Med. 2015;25:191--9.
